Tapewire

Nasdaq · USD

LGND

LIGAND PHARMACEUTICALS INC

Export transactions ↓
Tapewire entity
3825
SEC CIK
0000886163
Parsed reports
442

Last 12 months

Inside the activity.

0 purchase rows · 131 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202508
Dec 202508
Jan 202605
Feb 202605
Mar 2026032
Apr 2026011
May 2026014
Jun 2026016
Jul 202608
Aug 2026012
Sep 202606
Oct 202606

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
August 17, 2018 Filed Aug 17, 2018 23:37 UTC
HIGGINS JOHN LDirector · Chief Executive Officer
Exercise / conversionCommon Stock 12,993 $14.47 $188,008.71
Disclosure

SEC source: 0000886163-18-000121 · edgardoc.xml · nonDerivative · entry 3

HIGGINS JOHN L · CIK 0001208906 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 101,912

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on June 22, 2018, in accordance with Rule 10b5-1.

Read SEC document
August 16, 2018 Filed Aug 17, 2018 23:38 UTC
Davis Todd CDirector
SaleCommon Stock 5,833 $239.93 $1,399,505.27
Disclosure

SEC source: 0000886163-18-000122 · edgardoc.xml · nonDerivative · entry 1

Davis Todd C · CIK 0001392029 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,223

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $239.8845 to $240.3250, inclusive. The reporting person undertakes to provide, upon request to the Securities Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
August 16, 2018 Filed Aug 17, 2018 23:38 UTC
Aryeh JasonDirector
SaleCommon Stock 1,080 $245.00 $264,600.00
Disclosure

SEC source: 0000886163-18-000123 · edgardoc.xml · nonDerivative · entry 1

Aryeh Jason · CIK 0001376960 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Indirect

Disclosed balance after: 78,254

F1 · ownership.nature: All securities disclosed in this Form 4 are owned by certain funds managed by JALAA Equities, LP, JLV Investments, LP and affiliates (the "Funds"). Jason Aryeh is the General Partner of JALAA Equities, LP and a partner of JLV Investments, LP. By reason of the provisions of Rule 16a-1 under the Securities Exchange Act of 1934, as amended, JALAA Equities, LP, JLV Investments, LP and affiliates and Mr. Aryeh may be deemed to be the beneficial owners of the securities beneficially owned by the Funds.

Read SEC document
August 16, 2018 Filed Aug 17, 2018 23:37 UTC
HIGGINS JOHN LDirector · Chief Executive Officer
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 3,007 $0.00 Strike: $14.47 $0.00
Disclosure

SEC source: 0000886163-18-000121 · edgardoc.xml · derivative · entry 5

HIGGINS JOHN L · CIK 0001208906 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 171,993

Underlying: Common Stock · 3,007 shares

Expires 2022-02-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on June 22, 2018, in accordance with Rule 10b5-1.

F2 · derivative.exercise_date: Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant is 02/09/12.

Read SEC document
August 16, 2018 Filed Aug 17, 2018 23:37 UTC
HIGGINS JOHN LDirector · Chief Executive Officer
SaleCommon Stock 21,507 $241.33 $5,190,260.65
Disclosure

SEC source: 0000886163-18-000121 · edgardoc.xml · nonDerivative · entry 2

HIGGINS JOHN L · CIK 0001208906 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,919

F1 · shares: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on June 22, 2018, in accordance with Rule 10b5-1.

Read SEC document
August 16, 2018 Filed Aug 17, 2018 23:37 UTC
HIGGINS JOHN LDirector · Chief Executive Officer
Exercise / conversionCommon Stock 3,007 $14.47 $43,511.29
Disclosure

SEC source: 0000886163-18-000121 · edgardoc.xml · nonDerivative · entry 1

HIGGINS JOHN L · CIK 0001208906 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 110,426

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on June 22, 2018, in accordance with Rule 10b5-1.

Read SEC document
August 16, 2018 Filed Aug 17, 2018 23:37 UTC
Patel SunilDirector
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 7,335 $0.00 Strike: $32.30 $0.00
Disclosure

SEC source: 0000886163-18-000120 · edgardoc.xml · derivative · entry 9

Patel Sunil · CIK 0001503062 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,335 shares

Expires 2023-06-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 11, 2013, and fully vested on the first anniversary of the grant date.

Read SEC document
August 16, 2018 Filed Aug 17, 2018 23:37 UTC
Patel SunilDirector
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 7,335 $0.00 Strike: $12.53 $0.00
Disclosure

SEC source: 0000886163-18-000120 · edgardoc.xml · derivative · entry 8

Patel Sunil · CIK 0001503062 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,335 shares

Expires 2022-05-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Acquired by a grant of the Board of Directors of the Company at their annual meeting on May 31, 2012, and fully vested on the first anniversary of the grant date.

Read SEC document
August 16, 2018 Filed Aug 17, 2018 23:37 UTC
Patel SunilDirector
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 7,335 $0.00 Strike: $10.12 $0.00
Disclosure

SEC source: 0000886163-18-000120 · edgardoc.xml · derivative · entry 7

Patel Sunil · CIK 0001503062 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,335 shares

Expires 2021-06-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 01, 2011, and fully vested on the first anniversary of the grant date.

Read SEC document
August 16, 2018 Filed Aug 17, 2018 23:37 UTC
Patel SunilDirector
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 5,000 $0.00 Strike: $9.60 $0.00
Disclosure

SEC source: 0000886163-18-000120 · edgardoc.xml · derivative · entry 6

Patel Sunil · CIK 0001503062 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,000 shares

Expires 2020-10-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option becomes exercisable in 36 successive monthly installments upon completion of each calendar month of service beginning on the grant date.

Read SEC document
August 16, 2018 Filed Aug 17, 2018 23:37 UTC
Patel SunilDirector
SaleCommon Stock 42,287 $240.05 $10,150,808.29
Disclosure

SEC source: 0000886163-18-000120 · edgardoc.xml · nonDerivative · entry 5

Patel Sunil · CIK 0001503062 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,524

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $238.31 to $242.68, inclusive. The reporting person undertakes to provide, upon request to the Securities Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
August 16, 2018 Filed Aug 17, 2018 23:37 UTC
Patel SunilDirector
Exercise / conversionCommon Stock 7,335 $32.30 $236,920.50
Disclosure

SEC source: 0000886163-18-000120 · edgardoc.xml · nonDerivative · entry 4

Patel Sunil · CIK 0001503062 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,811

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 16, 2018 Filed Aug 17, 2018 23:37 UTC
Patel SunilDirector
Exercise / conversionCommon Stock 7,335 $12.53 $91,907.55
Disclosure

SEC source: 0000886163-18-000120 · edgardoc.xml · nonDerivative · entry 3

Patel Sunil · CIK 0001503062 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,476

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 16, 2018 Filed Aug 17, 2018 23:37 UTC
Patel SunilDirector
Exercise / conversionCommon Stock 7,335 $10.12 $74,230.20
Disclosure

SEC source: 0000886163-18-000120 · edgardoc.xml · nonDerivative · entry 2

Patel Sunil · CIK 0001503062 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,141

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 16, 2018 Filed Aug 17, 2018 23:37 UTC
Patel SunilDirector
Exercise / conversionCommon Stock 5,000 $9.60 $48,000.00
Disclosure

SEC source: 0000886163-18-000120 · edgardoc.xml · nonDerivative · entry 1

Patel Sunil · CIK 0001503062 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,806

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 06, 2018 Filed Aug 7, 2018 20:35 UTC
Korenberg Matthew EEVP,Finance & Strategy and CFO
Tax withholdingCommon Stock 836 $226.74 $189,554.64
Disclosure

SEC source: 0000886163-18-000111 · edgardoc.xml · nonDerivative · entry 1

Korenberg Matthew E · CIK 0001649903 · EVP,Finance & Strategy and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,559

F1 · shares: Represents shares withheld to satisfy tax withholding obligations upon the vesting of previously reported restricted stock units that were granted on 08/06/2015.

Read SEC document
July 02, 2018 Filed Jul 3, 2018 22:50 UTC SaleCommon Stock 2,500 $207.48 $518,699.25
Disclosure

SEC source: 0000886163-18-000102 · edgardoc.xml · nonDerivative · entry 1

KOZARICH JOHN W · CIK 0001223000 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,642

F1 · shares: The transaction reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 05, 2017, in accordance with Rule 10b5-1.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $205.06 to $208.68, inclusive. The reporting person undertakes to provide, upon request to the Securities Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
June 29, 2018 Filed Jul 3, 2018 19:27 UTC
Korenberg Matthew EEVP,Finance & Strategy and CFO
OtherCommon Stock 180 $117.84 $21,210.39
Disclosure

SEC source: 0000886163-18-000089 · edgardoc.xml · nonDerivative · entry 1

Korenberg Matthew E · CIK 0001649903 · EVP,Finance & Strategy and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,395

F1 · kind: Shares acquired under Ligand's employee stock purchase plan. Voluntary reporting exemption under Rule 16b-3(c).

Read SEC document
June 29, 2018 Filed Jul 3, 2018 19:27 UTC
Berkman Charles SSVP, Gen. Counsel & Secretary
OtherCommon Stock 180 $117.84 $21,210.39
Disclosure

SEC source: 0000886163-18-000088 · edgardoc.xml · nonDerivative · entry 1

Berkman Charles S · CIK 0001392266 · SVP, Gen. Counsel & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,763

F1 · kind: Shares acquired under Ligand's employee stock purchase plan. Voluntary reporting exemption under Rule 16b-3(c).

Read SEC document
June 19, 2018 Filed Jun 21, 2018 20:46 UTC
Patel SunilDirector
GrantNon-Qualified Stock Option (right to buy) · Derivative 2,474 $0.00 Strike: $76.77 $0.00
Disclosure

SEC source: 0000899243-18-017610 · doc4.xml · derivative · entry 2

Patel Sunil · CIK 0001503062 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,474

Underlying: Common Stock · 2,474 shares

Expires 2028-06-18

F1 · derivative.exercise_date: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 19, 2018. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 19, 2018 Filed Jun 21, 2018 20:46 UTC
Patel SunilDirector
GrantCommon Stock 493 $0.00 $0.00
Disclosure

SEC source: 0000899243-18-017610 · doc4.xml · nonDerivative · entry 1

Patel Sunil · CIK 0001503062 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,806

F1 · shares: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 19, 2018. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 19, 2018 Filed Jun 21, 2018 20:46 UTC
Davis Todd CDirector
GrantNon-Qualified Stock Option (right to buy) · Derivative 2,474 $0.00 Strike: $76.77 $0.00
Disclosure

SEC source: 0000899243-18-017609 · doc4.xml · derivative · entry 2

Davis Todd C · CIK 0001392029 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,474

Underlying: Common Stock · 2,474 shares

Expires 2028-06-18

F1 · derivative.exercise_date: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 19, 2018. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 19, 2018 Filed Jun 21, 2018 20:46 UTC
Davis Todd CDirector
GrantCommon Stock 493 $0.00 $0.00
Disclosure

SEC source: 0000899243-18-017609 · doc4.xml · nonDerivative · entry 1

Davis Todd C · CIK 0001392029 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,056

F1 · shares: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 19, 2018. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 19, 2018 Filed Jun 21, 2018 20:45 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 2,474 $0.00 Strike: $76.77 $0.00
Disclosure

SEC source: 0000899243-18-017608 · doc4.xml · derivative · entry 2

Gray Nancy Ryan · CIK 0001714949 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,474

Underlying: Common Stock · 2,474 shares

Expires 2028-06-18

F1 · derivative.exercise_date: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 19, 2018. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 19, 2018 Filed Jun 21, 2018 20:45 UTC GrantCommon Stock 493 $0.00 $0.00
Disclosure

SEC source: 0000899243-18-017608 · doc4.xml · nonDerivative · entry 1

Gray Nancy Ryan · CIK 0001714949 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,406

F1 · shares: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 19, 2018. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 19, 2018 Filed Jun 21, 2018 20:42 UTC
Aryeh JasonDirector
GrantNon-Qualified Stock Option (right to buy) · Derivative 2,474 $0.00 Strike: $76.77 $0.00
Disclosure

SEC source: 0000899243-18-017604 · doc4.xml · derivative · entry 4

Aryeh Jason · CIK 0001376960 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,474

Underlying: Common Stock · 2,474 shares

Expires 2028-06-18

F1 · derivative.exercise_date: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 19, 2018. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 19, 2018 Filed Jun 21, 2018 20:42 UTC
Aryeh JasonDirector
GrantCommon Stock 493 $0.00 $0.00
Disclosure

SEC source: 0000899243-18-017604 · doc4.xml · nonDerivative · entry 1

Aryeh Jason · CIK 0001376960 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,118

F1 · shares: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 19, 2018. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 19, 2018 Filed Jun 21, 2018 20:42 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 2,474 $0.00 Strike: $76.77 $0.00
Disclosure

SEC source: 0000899243-18-017603 · doc4.xml · derivative · entry 2

LAMATTINA JOHN L · CIK 0001216074 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,474

Underlying: Common Stock · 2,474 shares

Expires 2028-06-18

F1 · derivative.exercise_date: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 19, 2018. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 19, 2018 Filed Jun 21, 2018 20:42 UTC GrantCommon Stock 493 $0.00 $0.00
Disclosure

SEC source: 0000899243-18-017603 · doc4.xml · nonDerivative · entry 1

LAMATTINA JOHN L · CIK 0001216074 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,449

F1 · shares: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 19, 2018. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 19, 2018 Filed Jun 21, 2018 20:41 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 2,474 $0.00 Strike: $76.77 $0.00
Disclosure

SEC source: 0000899243-18-017599 · doc4.xml · derivative · entry 2

KOZARICH JOHN W · CIK 0001223000 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,474

Underlying: Common Stock · 2,474 shares

Expires 2028-06-18

F1 · derivative.exercise_date: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 19, 2018. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 19, 2018 Filed Jun 21, 2018 20:41 UTC GrantCommon Stock 493 $0.00 $0.00
Disclosure

SEC source: 0000899243-18-017599 · doc4.xml · nonDerivative · entry 1

KOZARICH JOHN W · CIK 0001223000 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,142

F1 · shares: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 19, 2018. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 19, 2018 Filed Jun 21, 2018 16:32 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 2,474 $0.00 Strike: $76.77 $0.00
Disclosure

SEC source: 0001104659-18-041511 · a4.xml · derivative · entry 2

Sabba Stephen L · CIK 0001442372 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,474

Underlying: Common Stock · 2,474 shares

Expires 2028-06-19

F2 · security: These securities, as represented in Column 5, were acquired by a grant of 2,474 shares approved by the Board of Directors of the Company at the 2018 Meeting. That grant (a) vests in full on the earlier of (i) the date of the next annual meeting of the Company stockholders following the grant date or (ii) on the first anniversary of the grant date, and (b) will vest immediately (i) upon a change in control or a hostile takeover of the Company or (ii) the death or permanent disability of the grantee if still serving at that time.

F2 · derivative.exercise_date: These securities, as represented in Column 5, were acquired by a grant of 2,474 shares approved by the Board of Directors of the Company at the 2018 Meeting. That grant (a) vests in full on the earlier of (i) the date of the next annual meeting of the Company stockholders following the grant date or (ii) on the first anniversary of the grant date, and (b) will vest immediately (i) upon a change in control or a hostile takeover of the Company or (ii) the death or permanent disability of the grantee if still serving at that time.

Read SEC document
June 19, 2018 Filed Jun 21, 2018 16:32 UTC GrantCommon Stock 493 $0.00 $0.00
Disclosure

SEC source: 0001104659-18-041511 · a4.xml · nonDerivative · entry 1

Sabba Stephen L · CIK 0001442372 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,856

F1 · security: These securities, as represented in Column 5, include a grant of 493 restricted shares approved by the Board of Directors of the Company at the 2018 Meeting, which shares will vest in full on the earlier of (a) the date of the next annual meeting of the Company stockholders following the grant date or (b) on the first anniversary of the grant date.

Read SEC document
June 19, 2018 Filed Jul 3, 2018 22:47 UTC Amendment
Aryeh JasonDirector
GrantNon-Qualified Stock Option (right to buy) · Derivative 2,474 $0.00 Strike: $195.91 $0.00
Disclosure

SEC source: 0000886163-18-000100 · edgardoc.xml · derivative · entry 1

Aryeh Jason · CIK 0001376960 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,474

Underlying: Common Stock · 2,474 shares

Expires 2028-06-18

F1 · derivative.exercise_price: This amendment is being filed to correct the exercise price listed in item 2 of Table II in order to reflect the market closing price on the grant date.

F2 · derivative.exercise_date: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 19, 2018. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 19, 2018 Filed Jul 3, 2018 22:45 UTC Amendment
Davis Todd CDirector
GrantNon-Qualified Stock Option (right to buy) · Derivative 2,474 $0.00 Strike: $195.91 $0.00
Disclosure

SEC source: 0000886163-18-000099 · edgardoc.xml · derivative · entry 1

Davis Todd C · CIK 0001392029 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,474

Underlying: Common Stock · 2,474 shares

Expires 2028-06-18

F1 · derivative.exercise_price: This amendment is being filed to correct the exercise price listed in item 2 of Table II in order to reflect the market closing price on the grant date.

F2 · derivative.exercise_date: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 19, 2018. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 19, 2018 Filed Jul 3, 2018 22:43 UTC Amendment GrantNon-Qualified Stock Option (right to buy) · Derivative 2,474 $0.00 Strike: $195.91 $0.00
Disclosure

SEC source: 0000886163-18-000098 · edgardoc.xml · derivative · entry 1

Gray Nancy Ryan · CIK 0001714949 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,474

Underlying: Common Stock · 2,474 shares

Expires 2028-06-18

F1 · derivative.exercise_price: This amendment is being filed to correct the exercise price listed in item 2 of Table II in order to reflect the market closing price on the grant date.

F2 · derivative.exercise_date: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 19, 2018. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 19, 2018 Filed Jul 3, 2018 22:42 UTC Amendment GrantNon-Qualified Stock Option (right to buy) · Derivative 2,474 $0.00 Strike: $195.91 $0.00
Disclosure

SEC source: 0000886163-18-000097 · edgardoc.xml · derivative · entry 1

KOZARICH JOHN W · CIK 0001223000 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,474

Underlying: Common Stock · 2,474 shares

Expires 2028-06-18

F1 · derivative.exercise_price: This amendment is being filed to correct the exercise price listed in item 2 of Table II in order to reflect the market closing price on the grant date.

F2 · derivative.exercise_date: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 19, 2018. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 19, 2018 Filed Jul 3, 2018 22:39 UTC Amendment GrantNon-Qualified Stock Option (right to buy) · Derivative 2,474 $0.00 Strike: $195.91 $0.00
Disclosure

SEC source: 0000886163-18-000096 · edgardoc.xml · derivative · entry 1

LAMATTINA JOHN L · CIK 0001216074 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,474

Underlying: Common Stock · 2,474 shares

Expires 2028-06-18

F1 · derivative.exercise_price: This amendment is being filed to correct the exercise price listed in item 2 of Table II in order to reflect the market closing price on the grant date.

F2 · derivative.exercise_date: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 19, 2018. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 19, 2018 Filed Jul 3, 2018 22:37 UTC Amendment
Patel SunilDirector
GrantNon-Qualified Stock Option (right to buy) · Derivative 2,474 $0.00 Strike: $195.91 $0.00
Disclosure

SEC source: 0000886163-18-000095 · edgardoc.xml · derivative · entry 1

Patel Sunil · CIK 0001503062 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,474

Underlying: Common Stock · 2,474 shares

Expires 2028-06-18

F1 · derivative.exercise_price: This amendment is being filed to correct the exercise price listed in item 2 of Table II in order to reflect the market closing price on the grant date.

F2 · derivative.exercise_date: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 19, 2018. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 19, 2018 Filed Jul 3, 2018 21:05 UTC Amendment GrantNon-Qualified Stock Option (right to buy) · Derivative 2,474 $0.00 Strike: $195.91 $0.00
Disclosure

SEC source: 0001104659-18-043872 · a4a.xml · derivative · entry 2

Sabba Stephen L · CIK 0001442372 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,474

Underlying: Common Stock · 2,474 shares

Expires 2028-06-19

F2 · security: These securities, as represented in Column 5, were acquired by a grant of 2,474 shares approved by the Board of Directors of the Company at the 2018 Meeting. That grant (a) vests in full on the earlier of (i) the date of the next annual meeting of the Company stockholders following the grant date or (ii) on the first anniversary of the grant date, and (b) will vest immediately (i) upon a change in control or a hostile takeover of the Company or (ii) the death or permanent disability of the grantee if still serving at that time.

F2 · derivative.exercise_date: These securities, as represented in Column 5, were acquired by a grant of 2,474 shares approved by the Board of Directors of the Company at the 2018 Meeting. That grant (a) vests in full on the earlier of (i) the date of the next annual meeting of the Company stockholders following the grant date or (ii) on the first anniversary of the grant date, and (b) will vest immediately (i) upon a change in control or a hostile takeover of the Company or (ii) the death or permanent disability of the grantee if still serving at that time.

Read SEC document
June 19, 2018 Filed Jul 3, 2018 21:05 UTC Amendment GrantCommon Stock 493 $0.00 $0.00
Disclosure

SEC source: 0001104659-18-043872 · a4a.xml · nonDerivative · entry 1

Sabba Stephen L · CIK 0001442372 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,856

F1 · security: These securities, as represented in Column 5, include a grant of 493 restricted shares approved by the Board of Directors of the Company at the 2018 Meeting, which shares will vest in full on the earlier of (a) the date of the next annual meeting of the Company stockholders following the grant date or (b) on the first anniversary of the grant date.

Read SEC document
June 04, 2018 Filed Jun 4, 2018 23:01 UTC Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 4,000 $0.00 Strike: $12.53 $0.00
Disclosure

SEC source: 0000886163-18-000080 · edgardoc.xml · derivative · entry 3

LAMATTINA JOHN L · CIK 0001216074 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,335

Underlying: Common Stock · 4,000 shares

Expires 2022-05-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 05, 2017, in accordance with Rule 10b5-1.

F3 · derivative.exercise_date: Acquired by a grant of the Board of Directors of the Company at their annual meeting on May 31, 2012, and fully vested on the first anniversary of the grant date.

Read SEC document
June 04, 2018 Filed Jun 4, 2018 23:01 UTC SaleCommon Stock 4,000 $194.51 $778,038.80
Disclosure

SEC source: 0000886163-18-000080 · edgardoc.xml · nonDerivative · entry 2

LAMATTINA JOHN L · CIK 0001216074 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,956

F1 · shares: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 05, 2017, in accordance with Rule 10b5-1.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $192.23 to $199.07, inclusive. The reporting person undertakes to provide, upon request to the Securities Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
June 04, 2018 Filed Jun 4, 2018 23:01 UTC Exercise / conversionCommon Stock 4,000 $12.53 $50,120.00
Disclosure

SEC source: 0000886163-18-000080 · edgardoc.xml · nonDerivative · entry 1

LAMATTINA JOHN L · CIK 0001216074 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,956

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 05, 2017, in accordance with Rule 10b5-1.

Read SEC document
May 15, 2018 Filed May 15, 2018 22:41 UTC
HIGGINS JOHN LDirector · Chief Executive Officer
Exercise / conversionIncentive Stock Option (right to buy) · Derivative 12,405 $0.00 Strike: $16.14 $0.00
Disclosure

SEC source: 0000886163-18-000069 · edgardoc.xml · derivative · entry 3

HIGGINS JOHN L · CIK 0001208906 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,790

Underlying: Common Stock · 12,405 shares

Expires 2019-02-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 20, 2017, in accordance with Rule 10b5-1.

F3 · derivative.exercise_date: Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant is 2/15/09.

Read SEC document
May 15, 2018 Filed May 15, 2018 22:41 UTC
HIGGINS JOHN LDirector · Chief Executive Officer
SaleCommon Stock 12,405 $179.97 $2,232,490.64
Disclosure

SEC source: 0000886163-18-000069 · edgardoc.xml · nonDerivative · entry 2

HIGGINS JOHN L · CIK 0001208906 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 107,419

F1 · shares: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 20, 2017, in accordance with Rule 10b5-1.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $179.34 to $180.82, inclusive. The reporting person undertakes to provide, upon request to the Securities Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
May 15, 2018 Filed May 15, 2018 22:41 UTC
HIGGINS JOHN LDirector · Chief Executive Officer
Exercise / conversionCommon Stock 12,405 $16.14 $200,216.70
Disclosure

SEC source: 0000886163-18-000069 · edgardoc.xml · nonDerivative · entry 1

HIGGINS JOHN L · CIK 0001208906 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 119,824

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 20, 2017, in accordance with Rule 10b5-1.

Read SEC document
May 14, 2018 Filed Feb 7, 2019 23:19 UTC GiftCommon Stock 600 $0.00 $0.00
Disclosure

SEC source: 0000886163-19-000029 · edgardoc.xml · nonDerivative · entry 1

KOZARICH JOHN W · CIK 0001223000 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,049

Read SEC document
May 10, 2018 Filed May 11, 2018 21:32 UTC
FOEHR MATTHEW WPresident and COO
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 8,881 $0.00 Strike: $14.47 $0.00
Disclosure

SEC source: 0000886163-18-000067 · edgardoc.xml · derivative · entry 5

FOEHR MATTHEW W · CIK 0001237556 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,675

Underlying: Common Stock · 8,881 shares

Expires 2022-02-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant is 02/09/12.

Read SEC document
May 10, 2018 Filed May 11, 2018 21:32 UTC
FOEHR MATTHEW WPresident and COO
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 1,055 $0.00 Strike: $9.97 $0.00
Disclosure

SEC source: 0000886163-18-000067 · edgardoc.xml · derivative · entry 4

FOEHR MATTHEW W · CIK 0001237556 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,026

Underlying: Common Stock · 1,055 shares

Expires 2021-04-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant is 04/18/11.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.